Materials & Resources » Chemicals | PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc. | Balance Sheet

Fiscal year is May-April. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,616.50
2,699.70
1,920.80
3,464.20
1,059.80
Other Current Assets
570.10
1,468.30
110.00
74.30
224.10
Total Current Assets
4,186.60
4,168.00
2,030.90
3,538.50
1,283.90
Total Investments and Advances
1,572.20
1,572.20
1,572.20
1,572.20
1,572.20
Intangible Assets
3,549.40
3,549.40
3,549.40
3,549.40
3,549.40
Other Assets
7.90
7.90
7.90
7.40
7.40
Total Assets
9,316.10
9,297.50
7,160.30
8,667.50
6,412.90
ST Debt & Current Portion LT Debt
143.90
-
-
-
-
Accounts Payable
188.00
-
-
-
352.60
Other Current Liabilities
41.80
1,520.40
637.60
580.20
291.50
Total Current Liabilities
373.70
1,520.40
637.60
580.20
644.20
Total Liabilities
373.70
1,520.40
637.60
580.20
644.20
Common Equity (Total)
8,942.40
7,777.10
6,522.70
8,087.20
5,768.70
Total Shareholders' Equity
8,942.40
7,777.10
6,522.70
8,087.20
5,768.70
Total Equity
8,942.40
7,777.10
6,522.70
8,087.20
5,768.70
Liabilities & Shareholders' Equity
9,316.10
9,297.50
7,160.30
8,667.50
6,412.90

About PharmaCyte Biotech

View Profile
Address
23046 Avenida de la Carlota
Laguna Hills California 92653
United States
Employees -
Website http://pharmacyte.com
Updated 07/08/2019
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.